Specific Treatment Issues for Pregnant Women With HIV

Hide Archived (Historical) Articles

Taking HIV Meds Throughout Pregnancy Does More Good Than Harm, Study Suggests (September 15, 2008)
From aidsmap.com
HIV Meds During Pregnancy Do Not Increase Birth Defect Risk, Major Study Finds (March 27, 2007)
In aidsmap.com
Six-Month Delay in Onset of Nevirapine-Based Antiretroviral Therapy Can Prevent Drug Resistance Following Single-Dose Nevirapine During Labor, Study Says (January 11, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Exposure to ARVs in Womb Does Not Affect Child's Mental Development, Canadians Report (October 31, 2006)
From aidsmap.com
Nevirapine Resistance May Persist in Some Pregnant Women, Study Finds (May 3, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Efavirenz-Associated Neural Tube Defects Reported in Infants; Pregnancy Category Changed From C to D (March 31, 2005)
[Archived Article]
From U.S. Food and Drug Administration
Crixivan (Indinavir) Label Revised -- Not Recommended for HIV-Infected Pregnant Patients (December 27, 2004)
From U.S. Food and Drug Administration
Nelfinavir Levels a Third Lower in Pregnant Women (August 31, 2004)
[Archived Article]
However, the reduction doesn't appear to increase the baby's risk of contracting HIV, and in all but one case the pregnant women still had undetectable viral loads.
From aidsmap.com
HIV Drug Classifications for Pregnant Women (May 25, 2004)
A brief review of which HIV medications have been studied for their safety in pregnant women.
To read PDF, click here
From PositiveWords
California: Program Helps Pregnant Mothers Infected With HIV (May 13, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Birth Defect in Baby Born to Efavirenz User (February 6, 2002)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
Cesarean Section Morbidity (Summer/Autumn 2001)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
FDA Issues Warning About d4T and ddI During Pregnancy (January 22, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
FDA/Bristol Myers Squibb Issues Caution for HIV Combination Therapy With Zerit and Videx in Pregnant Women (January 5, 2001)
[Archived Article]
From U.S. Food and Drug Administration
Important Drug Warning (January 5, 2001)
[Archived Article]
From U.S. Food and Drug Administration
Preventing Mother-to-Child HIV Transmission (October 25, 2000)
[Archived Article]
Technical experts recommend use of antiretroviral regimens beyond pilot projects.
From UNAIDS
Benefits of Resistance Testing During Pregnancy (December 1999)
[Archived Article]
In WISE Words, from Project Inform
Fungal Infections During Pregnancy (September 1999)
[Archived Article]
In Project Inform Perspective, from Project Inform
Elective Caesareans (April 1999)
[Archived Article]
In Body Positive, from Body Positive
98% Sure (October 1998)
[Archived Article]
Reducing transmission risk through cesarean section.
In AIDS Care, from San Francisco General Hospital
Good for Both Mother and Child (October 1998)
[Archived Article]
The importance of good prenatal care for pregnant women with HIV.
In AIDS Care, from San Francisco General Hospital
Efavirenz Pregnancy Warning (March 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
Cocktails During Pregnancy (February 1998)
[Archived Article]
In AIDS Care, from San Francisco General Hospital
Highlights From the Conference on Global Strategies on the Prevention of Mother-to-Child HIV Transmission (January 1998)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation

My Health Tracker

Widgets and RSS Feeds

U.S. ASO Finder

The First Man to Be Cured of AIDS: An Update on the Amazing Story -- This Month in HIV

OIs and Co-Infections and STIs -- Oh, My!

HIV Antiretrovirals in Development: An Update From ICAAC 2009

World AIDS Day 2009: Home

Back From the Brink: A Blog Entry by Thomas DeLorenzo

More >>

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.